Placental protein measurements in complicated pregnancies. II. Pregnancy‐related hypertension
- 1 December 1984
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 91 (12) , 1224-1229
- https://doi.org/10.1111/j.1471-0528.1984.tb04741.x
Abstract
Maternal serum levels of pregnancy-associated plasma protein A (PAPP-A), human placental lactogen (hPL) and schwangerschafts-protein 1 (SP1) were measured serially during the second and third trimesters in 753 women with a normal pregnancy when recruited during the second trimester. Thirty-seven pregnancies were complicated by pregnancy-related hypertension after 28 weeks gestation. Maternal levels of PAPP-A and SP1, and trends of levels in individual patients, could generally not be distinguished from those seen in patients with a normal pregnancy, and were unrelated to the time of onset of the disease, its severity or the occurrence of other complications with one exception, in which decreased levels of SP1 and hPL were seen. Mean levels of hPL were significantly lower (P less than 0.05) at 35 weeks gestation. These data suggest that the measurement of the placental proteins examined here is of no value in the prediction of occurrence of pregnancy-related hypertension.Keywords
This publication has 11 references indexed in Scilit:
- Pregnancy-associated plasma protein A: A possible marker in the classification and prenatal diagnosis of Cornelia de Lange syndromePrenatal Diagnosis, 1983
- Effect of anticoagulants on the measurement of pregnancy-associated plasma protein-A (PAPP-A)BJOG: An International Journal of Obstetrics and Gynaecology, 1983
- Pregnancy-associated plasma protein A in the prediction of early pregnancy failureAmerican Journal of Obstetrics and Gynecology, 1983
- Specific and reversible interaction between pregnancy-associated plasma protein A and heparinPlacenta, 1983
- Pregnancy Associated Plasma Protein‐A: Interaction with Heparin in Crossed Affinity lmmunoelectrophoresisAustralian and New Zealand Journal of Medicine, 1981
- Specific interaction between placentae protein 5 and heparinClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- Molecular heterogeneity of placental protein 5 (pp5) in late pregnancy serum and plasma: evidence for a heparin-pp5 polymerClinica Chimica Acta; International Journal of Clinical Chemistry, 1980
- TESTS OF FETAL WELLBEING IN THE THIRD TRIMESTER OF PREGNANCYBJOG: An International Journal of Obstetrics and Gynaecology, 1980
- Assay of a placental protein to determine fetal risk.BMJ, 1980
- Pregnancy‐Specific β‐1 Glycoprotein (SP‐1) in Normal and Abnormal PregnancyAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1978